MS VLPs delivered long non-coding RNA maternally expressed gene 3 (MEG3) specifically to epidermal growth factor receptor (EGFR)-positive hepatocellular carcinoma (HCC) cell lines, without activating EGFR downstream signaling pathways. The gene discussed is MEG3; the disease is hepatocellular carcinoma.